JP2023529095A5 - - Google Patents
Info
- Publication number
- JP2023529095A5 JP2023529095A5 JP2022573504A JP2022573504A JP2023529095A5 JP 2023529095 A5 JP2023529095 A5 JP 2023529095A5 JP 2022573504 A JP2022573504 A JP 2022573504A JP 2022573504 A JP2022573504 A JP 2022573504A JP 2023529095 A5 JP2023529095 A5 JP 2023529095A5
- Authority
- JP
- Japan
- Prior art keywords
- botulinum toxin
- wrinkles
- injection
- injected
- botulinum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2026018408A JP2026077675A (ja) | 2020-06-05 | 2026-02-06 | 高用量低体積のボツリヌス毒素による顔のシワの治療 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20178574 | 2020-06-05 | ||
| EP20178574.8 | 2020-06-05 | ||
| PCT/EP2021/064986 WO2021245223A1 (en) | 2020-06-05 | 2021-06-04 | High dose and low volume botulinum toxin treatment of facial wrinkles |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026018408A Division JP2026077675A (ja) | 2020-06-05 | 2026-02-06 | 高用量低体積のボツリヌス毒素による顔のシワの治療 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023529095A JP2023529095A (ja) | 2023-07-07 |
| JP2023529095A5 true JP2023529095A5 (enExample) | 2024-06-03 |
Family
ID=71016459
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022573504A Pending JP2023529095A (ja) | 2020-06-05 | 2021-06-04 | 高用量低体積のボツリヌス毒素による顔のシワの治療 |
| JP2026018408A Pending JP2026077675A (ja) | 2020-06-05 | 2026-02-06 | 高用量低体積のボツリヌス毒素による顔のシワの治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2026018408A Pending JP2026077675A (ja) | 2020-06-05 | 2026-02-06 | 高用量低体積のボツリヌス毒素による顔のシワの治療 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US12599550B2 (enExample) |
| EP (2) | EP4161562B1 (enExample) |
| JP (2) | JP2023529095A (enExample) |
| KR (1) | KR20230020961A (enExample) |
| CN (1) | CN115666629A (enExample) |
| AU (1) | AU2021286196A1 (enExample) |
| BR (1) | BR112022023413A2 (enExample) |
| CA (1) | CA3177835A1 (enExample) |
| ES (1) | ES3013130T3 (enExample) |
| IL (1) | IL298399A (enExample) |
| MX (1) | MX2022014564A (enExample) |
| TW (1) | TW202214211A (enExample) |
| WO (1) | WO2021245223A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL298399A (en) | 2020-06-05 | 2023-01-01 | Merz Pharma Gmbh & Co Kgaa | Treatment of facial wrinkles with the botulinum toxin in high dose and low volume |
| TWI852454B (zh) * | 2022-04-01 | 2024-08-11 | 大陸商重慶譽顏製藥有限公司 | 一種肉毒毒素蛋白組合物、製備方法及其應用 |
| KR20250113431A (ko) * | 2022-11-28 | 2025-07-25 | 메르츠 파마 게엠베하 운트 코. 카가아 | 목을 재생하기 위한 고 농도 보툴리눔 독소 치료 |
| WO2025231403A1 (en) * | 2024-05-03 | 2025-11-06 | Revivity Pharma Corporation | Methods of administering and manufacturing toxic compounds |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19925739A1 (de) | 1999-06-07 | 2000-12-21 | Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh | Therapeutikum mit einem Botulinum-Neurotoxin |
| US7691394B2 (en) * | 2002-05-28 | 2010-04-06 | Botulinum Toxin Research Associates, Inc. | High-potency botulinum toxin formulations |
| DE10333317A1 (de) | 2003-07-22 | 2005-02-17 | Biotecon Therapeutics Gmbh | Formulierung für Proteinarzneimittel ohne Zusatz von humanem Serumalbumin (HSA) |
| EP1786459B1 (en) | 2004-07-26 | 2014-02-12 | Merz Pharma GmbH & Co. KGaA | Therapeutic composition whit a botulinum neurotoxin |
| EP2072039A1 (en) * | 2007-12-21 | 2009-06-24 | Merz Pharma GmbH & Co.KGaA | Use of a neurotoxic component of Clostridium botulinum toxin complex to reduce or prevent side effects |
| MY155049A (en) | 2008-03-14 | 2015-08-28 | Allergan Inc | Immuno-based botolinum toxin serotype a activity assay |
| LT2761065T (lt) * | 2011-09-29 | 2018-01-10 | Cellsnap, Llc | Kompozicijos ir būdai toksigeniškumo testavimui |
| US11976110B2 (en) | 2013-06-28 | 2024-05-07 | Merz Pharma Gmbh & Co. Kgaa | Means and methods for the determination of the biological activity of neurotoxin polypeptides in cells |
| US9480731B2 (en) * | 2013-12-12 | 2016-11-01 | Medy-Tox, Inc. | Long lasting effect of new botulinum toxin formulations |
| RU2020121540A (ru) | 2017-12-04 | 2022-01-10 | Реванс Терапьютикс, Инк. | Инъецируемые составы ботулинического токсина и способы их применения с высокими показателями ответа и длительной продолжительностью эффекта |
| IL298399A (en) | 2020-06-05 | 2023-01-01 | Merz Pharma Gmbh & Co Kgaa | Treatment of facial wrinkles with the botulinum toxin in high dose and low volume |
-
2021
- 2021-06-04 IL IL298399A patent/IL298399A/en unknown
- 2021-06-04 EP EP21728601.2A patent/EP4161562B1/en active Active
- 2021-06-04 JP JP2022573504A patent/JP2023529095A/ja active Pending
- 2021-06-04 AU AU2021286196A patent/AU2021286196A1/en active Pending
- 2021-06-04 BR BR112022023413A patent/BR112022023413A2/pt unknown
- 2021-06-04 CN CN202180037805.1A patent/CN115666629A/zh active Pending
- 2021-06-04 KR KR1020227040449A patent/KR20230020961A/ko active Pending
- 2021-06-04 EP EP24206746.0A patent/EP4467202A3/en active Pending
- 2021-06-04 WO PCT/EP2021/064986 patent/WO2021245223A1/en not_active Ceased
- 2021-06-04 TW TW110120421A patent/TW202214211A/zh unknown
- 2021-06-04 CA CA3177835A patent/CA3177835A1/en active Pending
- 2021-06-04 ES ES21728601T patent/ES3013130T3/es active Active
- 2021-06-04 MX MX2022014564A patent/MX2022014564A/es unknown
- 2021-06-04 US US18/007,712 patent/US12599550B2/en active Active
-
2026
- 2026-01-20 US US19/453,776 patent/US20260144733A1/en active Pending
- 2026-02-06 JP JP2026018408A patent/JP2026077675A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023517727A5 (enExample) | ||
| FI3481852T3 (fi) | Uusi botulinum-neurotoksiini ja sen johdannaisia | |
| Seo | Botulinum toxin for Asians | |
| ES2390033B1 (es) | Exopolisacárido para el tratamiento y/o cuidado de la piel, mucosas, cabello y/o uñas. | |
| CN101917960A (zh) | 肉毒杆菌毒素复合物的神经毒成分在减少或预防副作用中的应用 | |
| JP2019216735A5 (enExample) | ||
| JP2016540785A5 (enExample) | ||
| JP6877560B2 (ja) | ボツリヌス毒素を含む安定した液状組成物 | |
| JP2015519362A5 (enExample) | ||
| JP2011506511A5 (enExample) | ||
| JP7604020B2 (ja) | 環状ペプチド並びに該環状ペプチドを含む医薬品、外用剤および化粧料 | |
| CN109562148A (zh) | 用色氨酸或酪氨酸稳定的液体神经毒素制剂 | |
| JP2026077675A (ja) | 高用量低体積のボツリヌス毒素による顔のシワの治療 | |
| CN103501802B (zh) | 皮肤疤痕治疗用药物组合物及利用其的皮肤疤痕治疗方法 | |
| CN105748396A (zh) | 一种含有珍珠粉的美白护肤乳液 | |
| TW202435908A (zh) | 組成物及應用其之注射裝置 | |
| CN118924647A (zh) | 具备dna钠和rna的抗皱组合物 | |
| CN105748330A (zh) | 一种美白护肤品 | |
| US20190000937A1 (en) | Botulinum toxin for use in the treatment of paratonia | |
| JP2024543080A (ja) | ボツリヌス毒素組成物 | |
| JP2019137634A (ja) | 加水分解卵殻膜成分が配合されている美容液 | |
| RU2024129879A (ru) | Лечение морщин верхней части лица | |
| CN105434303B (zh) | 一种祛皱组合物及其皮肤外用制剂和该组合物的应用 | |
| Wu et al. | Botulinum toxin for skin rejuvenation | |
| CN105662919A (zh) | 一种含有杏仁油的美白护肤乳液 |